Drugs / Chloral Hydrate

Trials 10

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/21 trial
Phase 1/2 NCT01128270 Apr 2010 → Oct 2012 — University of Florida Completed No outcome recorded
Phase 33 trials
Phase 3 NCT02374567 Jan 2015 → Jun 2017 anxiety disorder, dementia, depressive disorder, schizophrenia +1 Hannover Medical School Terminated No outcome recorded
Phase 3 NCT02195661 Apr 2014 → Sep 2017 epilepsy University of Cape Town Completed No outcome recorded
Phase 3 NCT01083797 Dec 2009 → Mar 2013 brain disorder Federal University of Minas Gerais Completed No outcome recorded
Phase 42 trials · 1 met primary
Phase 4 NCT06053840 Sep 2023 → Apr 2024 insomnia Pharmanovia Completed Met primary
Phase 4 NCT01255904 Aug 2011 → Nov 2014 — Baylor College of Medicine Completed No outcome recorded
Phase not applicable4 trials
— NCT06606899 Sep → Dec 2024 — Ain Shams University Completed No outcome recorded
— NCT06389318 Mar 2023 → Mar 2024 hernia, double inguinal Benha University Completed No outcome recorded
— NCT05492812 Jan → Dec 2021 — Suleyman Demirel University Completed No outcome recorded
— NCT01149226 May → Dec 2010 — Yonsei University Completed No outcome recorded
Comparator or background therapy9 trials
Phase 2 NCT01402596 Comparator Aug 2011 → Aug 2012 traumatic brain injury University of Sao Paulo Withdrawn No outcome recorded
Phase 2 NCT00464451 Comparator Aug 2009 → Dec 2010 — Wesley Medical Center Withdrawn No outcome recorded
Phase 2 NCT00949780 Comparator Oct 2007 → Mar 2008 hypotonia, congenital nystagmus, ataxia, and abnormal auditory brainstem responses Pontifical Catholic University of São Paulo Completed No outcome recorded
Phase 4 NCT02239445 Comparator Sep 2014 → May 2015 — Guangzhou Women and Children's Medical Center Completed No outcome recorded
Phase 4 NCT02523144 Comparator Sep 2014 → May 2017 heart disorder Children's Hospital Medical Center, Cincinnati Completed No outcome recorded

News releases announcing trial results or a regulatory action · 1

DateIssuerRelease
2024-10-02 Pharmanovia Results New Pharmanovia study results reveal chloral hydrate noticeably improves severe insomnia within two weeks pharmanovia.com ↗
The topline readout found that chloral hydrate significantly improved insomnia symptoms in adults with severe insomnia.

All press releases naming this drug 1 release

DateIssuerRelease

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 20 sources stand behind the page.

FieldValueCited text
Known as chloral hydrate ClinicalTrials.gov intervention name — accepted as the source's own label NCT04820205 ↗
18

NCT02239445 ↗

NCT03242629 ↗

NCT02195661 ↗

NCT01128270 ↗

NCT01149226 ↗

NCT06389318 ↗

NCT05492812 ↗

NCT01083797 ↗

NCT02523144 ↗

NCT00949780 ↗

Show 8 more sources

Known as Chlorali hydras ChEMBL registry synonym — accepted as the source's own label CHEMBL455917 ↗
Known as Chloralum ChEMBL registry synonym — accepted as the source's own label CHEMBL455917 ↗
Known as Cloral hydrate ChEMBL registry synonym — accepted as the source's own label CHEMBL455917 ↗
Known as Noctec ChEMBL registry synonym — accepted as the source's own label CHEMBL455917 ↗
Known as NSC-3210 ChEMBL registry synonym — accepted as the source's own label CHEMBL455917 ↗
Modality Small molecule — CHEMBL455917 ↗
Route Oral “per os” NCT00464451 ↗